|
BCDIN3D expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.980400E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.547600E-02 |
| Normal-vs-Stage2 |
1.665770E-01 |
| Normal-vs-Stage3 |
8.016500E-04 |
| Normal-vs-Stage4 |
1.808390E-01 |
| Stage1-vs-Stage2 |
7.641200E-01 |
| Stage1-vs-Stage3 |
7.061500E-02 |
| Stage1-vs-Stage4 |
9.726200E-01 |
| Stage2-vs-Stage3 |
2.465000E-01 |
| Stage2-vs-Stage4 |
8.559000E-01 |
| Stage3-vs-Stage4 |
1.948960E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.761730E-02 |
| Normal-vs-AfricanAmerican |
2.616600E-01 |
| Normal-vs-Asian |
4.705500E-02 |
| Caucasian-vs-AfricanAmerican |
4.579000E-01 |
| Caucasian-vs-Asian |
5.354400E-01 |
| AfricanAmerican-vs-Asian |
4.136400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.349800E-02 |
| Normal-vs-Female |
1.049240E-01 |
| Male-vs-Female |
8.703400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.528500E-02 |
| Normal-vs-Extreme_Weight |
1.513730E-02 |
| Normal-vs-Obese |
7.678000E-02 |
| Normal-vs-Extreme_Obese |
6.487500E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.810800E-01 |
| Normal_Weight-vs-Obese |
7.092200E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.786400E-01 |
| Extreme_Weight-vs-Obese |
5.550400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.500800E-01 |
| Obese-vs-Extreme_Obese |
6.927400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.395400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.139400E-01 |
| Normal-vs-Age(61-80Yrs) |
5.523000E-03 |
| Normal-vs-Age(81-100Yrs) |
1.009630E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.759050E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.137600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.222000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.792400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.620180E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.329400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.282800E-01 |
| Normal-VS-Type2 PRCC |
1.7030999999168E-07 |
| Normal-VS-KIRP CIMP |
1.422100E-02 |
| Normal-VS-Unclassified PRCC |
5.141800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.09639999698896E-09 |
| Type1 PRCC-VS-KIRP CIMP |
1.225240E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.501900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.478400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.489670E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.461600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.380500E-03 |
| Normal-vs-N1 |
2.808200E-02 |
| Normal-vs-N2 |
3.862400E-02 |
| N0-vs-N1 |
7.043000E-01 |
| N0-vs-N2 |
7.095400E-01 |
| N1-vs-N2 |
5.699000E-01 |
|
|
